2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common Stock Value | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | NA | NA | 0.00 | NA | |
Weighted Average Number Of Diluted Shares Outstanding | 50.57 | NA | 42.48 | 42.47 | 42.44 | NA | 42.39 | 42.38 | NA | 42.16 | 41.91 | 41.77 | NA | 7.70 | 7.65 | NA | NA | NA | |
Weighted Average Number Of Shares Outstanding Basic | 50.57 | NA | 42.48 | 42.47 | 42.44 | NA | 42.39 | 42.38 | NA | 42.16 | 41.91 | 41.77 | NA | 7.70 | 7.65 | NA | NA | NA | |
Earnings Per Share Basic | -0.37 | -0.41 | -0.65 | -0.50 | -0.49 | -0.60 | -0.58 | -0.65 | 0.19 | -0.41 | -0.56 | -0.28 | 0.85 | -1.54 | -0.81 | NA | NA | NA | |
Earnings Per Share Diluted | -0.37 | -0.41 | -0.65 | -0.50 | -0.49 | -0.60 | -0.58 | -0.65 | 0.19 | -0.41 | -0.56 | -0.28 | 0.85 | -1.54 | -0.81 | NA | NA | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue From Contract With Customer Excluding Assessed Tax | 1.11 | 0.71 | 0.69 | 0.20 | 0.06 | 0.39 | 0.21 | 0.05 | 30.08 | 1.90 | -4.23 | 2.27 | 1.34 | 2.44 | 3.18 | 2.98 | 2.82 | 1.78 | |
Revenues | 1.11 | 0.71 | 0.69 | 0.20 | 0.06 | 0.39 | 0.21 | 0.05 | 30.08 | 1.90 | -4.23 | 2.27 | 1.34 | 2.44 | 3.18 | 2.98 | 2.82 | 1.78 | |
Operating Expenses | 21.16 | 19.66 | 29.28 | 22.95 | 21.72 | 26.67 | 25.44 | 27.71 | 20.83 | 19.48 | 20.28 | 14.69 | 13.35 | 14.27 | 9.50 | 9.74 | 10.45 | 9.31 | |
Research And Development Expense | 16.26 | 15.23 | 24.21 | 18.20 | 16.67 | 21.89 | 18.86 | 22.96 | 16.21 | 15.14 | 14.88 | 10.34 | 9.79 | 11.80 | 7.75 | 8.14 | 8.77 | 7.95 | |
General And Administrative Expense | 4.89 | 4.44 | 5.07 | 4.74 | 5.05 | 4.78 | 6.58 | 4.75 | 4.62 | 4.34 | 5.40 | 4.36 | 3.57 | 2.47 | 1.75 | 1.60 | 1.67 | 1.37 | |
Operating Income Loss | -20.04 | -18.95 | -28.60 | -22.75 | -21.66 | -26.28 | -25.23 | -27.66 | 9.25 | -17.58 | -24.51 | -12.42 | -12.01 | -11.84 | -6.32 | -6.76 | -7.62 | -7.53 | |
Allocated Share Based Compensation Expense | 2.48 | 1.64 | 1.76 | 1.85 | 1.68 | 1.69 | 1.72 | 1.53 | 1.22 | 1.34 | 1.73 | 1.18 | 0.64 | 0.31 | 0.14 | 0.17 | 0.16 | 0.14 | |
Net Income Loss | -18.50 | -17.69 | -27.54 | -21.35 | -20.72 | -25.41 | -24.64 | -27.37 | 7.85 | -17.41 | -23.60 | -11.81 | -12.01 | -11.83 | -5.97 | -6.79 | -7.37 | -7.28 | |
Comprehensive Income Net Of Tax | -18.52 | -17.69 | -27.46 | -21.08 | -20.19 | -24.95 | -24.86 | -27.95 | 9.11 | -17.62 | -24.56 | -12.41 | -12.06 | -11.86 | -6.30 | -6.49 | -7.43 | -7.27 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | 146.34 | 159.56 | 130.46 | 155.27 | 177.68 | 205.32 | 222.94 | 251.34 | 298.58 | 310.57 | 323.78 | 336.85 | 348.99 | 144.86 | NA | NA | 44.97 | NA | |
Liabilities | 17.52 | 14.86 | 17.67 | 16.81 | 20.02 | 29.17 | 23.52 | 28.81 | 26.80 | 49.40 | 46.69 | 38.19 | 39.13 | 37.11 | NA | NA | 30.45 | NA | |
Liabilities And Stockholders Equity | 146.34 | 159.56 | 130.46 | 155.27 | 177.68 | 205.32 | 222.94 | 251.34 | 298.58 | 310.57 | 323.78 | 336.85 | 348.99 | 144.86 | NA | NA | 44.97 | NA | |
Stockholders Equity | 128.81 | 144.71 | 112.78 | 138.46 | 157.65 | 176.16 | 199.42 | 222.53 | 271.79 | 261.17 | 277.09 | 298.66 | 309.86 | -58.36 | -47.03 | -41.09 | -34.55 | -27.28 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | 131.08 | 143.22 | 112.99 | 136.45 | 157.84 | 184.58 | 201.52 | 229.42 | 288.27 | 301.64 | 315.88 | 331.08 | 345.64 | 142.25 | NA | NA | 42.44 | NA | |
Cash And Cash Equivalents At Carrying Value | 76.00 | 125.63 | 40.63 | 71.89 | 66.04 | 47.38 | 39.76 | 37.87 | 92.27 | 85.09 | 86.49 | 84.73 | 157.90 | 128.60 | NA | NA | 7.01 | NA | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 76.00 | 125.63 | 40.63 | 71.89 | 66.04 | 47.38 | 39.76 | 37.87 | 92.27 | 85.09 | 86.49 | 84.73 | 157.90 | 128.60 | 131.04 | 37.69 | 7.01 | 15.23 | |
Prepaid Expense And Other Assets Current | 16.44 | 12.60 | 11.91 | 19.28 | 22.34 | 23.30 | 16.40 | 15.18 | 19.46 | 11.43 | 11.08 | 9.90 | 10.19 | 7.32 | NA | NA | 3.35 | NA | |
Available For Sale Securities Debt Securities | NA | 44.66 | 60.44 | 45.28 | 69.45 | 113.90 | NA | NA | 176.54 | 205.12 | 218.30 | 236.44 | 177.55 | 6.34 | NA | NA | 32.07 | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Property Plant And Equipment Gross | NA | 23.31 | NA | NA | NA | 23.38 | NA | NA | 12.72 | NA | NA | NA | 4.48 | NA | NA | NA | 3.30 | NA | |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | NA | 9.51 | NA | NA | NA | 5.71 | NA | NA | 2.78 | NA | NA | NA | 1.48 | NA | NA | NA | 0.86 | NA | |
Property Plant And Equipment Net | 12.83 | 13.80 | 14.80 | 16.02 | 16.89 | 17.67 | 18.24 | 18.76 | 9.94 | 8.65 | 7.57 | 5.41 | 3.00 | 2.52 | NA | NA | 2.44 | NA | |
Other Assets Noncurrent | 2.43 | 2.54 | 2.67 | 2.81 | 2.95 | 3.07 | 3.19 | 3.16 | 0.38 | 0.27 | 0.33 | 0.36 | 0.35 | 0.09 | NA | NA | 0.09 | NA | |
Available For Sale Debt Securities Amortized Cost Basis | NA | 44.66 | 60.44 | 45.35 | 69.79 | 114.78 | 146.69 | 177.48 | 177.10 | 206.95 | 219.92 | 237.10 | 177.61 | 6.35 | NA | NA | 32.02 | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liabilities Current | 14.33 | 11.45 | 14.06 | 12.99 | 16.01 | 24.96 | 19.14 | 24.25 | 24.59 | 19.84 | 15.11 | 17.90 | 16.83 | 16.48 | NA | NA | 19.98 | NA | |
Accounts Payable Current | 2.15 | 1.59 | 2.02 | 2.01 | 5.13 | 7.17 | 3.04 | 5.67 | 10.01 | 3.25 | 1.01 | 3.00 | 1.75 | 1.35 | NA | NA | 3.05 | NA | |
Other Accrued Liabilities Current | 0.36 | 1.04 | 0.22 | 0.18 | 1.63 | 1.17 | 1.29 | 2.45 | 1.00 | 0.64 | 1.25 | 0.57 | 0.42 | 0.79 | NA | NA | 0.42 | NA | |
Contract With Customer Liability Current | 4.61 | 0.34 | 0.56 | 0.74 | NA | NA | NA | NA | NA | 2.80 | 2.78 | 9.66 | 7.73 | 8.61 | NA | NA | 12.89 | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Lease Liability Noncurrent | 3.19 | 3.41 | 3.62 | 3.82 | 4.01 | 4.20 | 4.39 | 4.57 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stockholders Equity | 128.81 | 144.71 | 112.78 | 138.46 | 157.65 | 176.16 | 199.42 | 222.53 | 271.79 | 261.17 | 277.09 | 298.66 | 309.86 | -58.36 | -47.03 | -41.09 | -34.55 | -27.28 | |
Common Stock Value | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | NA | NA | 0.00 | NA | |
Additional Paid In Capital | 453.64 | 451.01 | 401.39 | 399.61 | 397.72 | 396.04 | 394.35 | 392.60 | 389.41 | 387.90 | 386.21 | 383.22 | 382.01 | 1.73 | NA | NA | 0.89 | NA | |
Retained Earnings Accumulated Deficit | -324.81 | -306.31 | -288.62 | -261.08 | -239.74 | -219.01 | -193.60 | -168.97 | -117.07 | -124.91 | -107.50 | -83.91 | -72.09 | -60.08 | NA | NA | -35.49 | NA | |
Accumulated Other Comprehensive Income Loss Net Of Tax | -0.01 | 0.00 | 0.01 | -0.07 | -0.34 | -0.88 | -1.33 | -1.11 | -0.56 | -1.83 | -1.62 | -0.66 | -0.06 | -0.01 | NA | NA | 0.05 | NA | |
Stock Issued During Period Value New Issues | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2.48 | NA | 1.76 | 1.85 | 1.68 | NA | 1.72 | 1.53 | NA | 1.34 | 1.73 | 1.18 | NA | 0.31 | 0.14 | 0.18 | NA | 0.14 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -16.16 | -19.42 | -16.73 | -18.62 | -26.46 | -23.84 | -28.06 | -16.32 | -18.72 | -12.99 | -14.34 | -11.07 | -14.04 | -11.35 | 2.19 | -10.45 | -7.62 | NA | |
Net Cash Provided By Used In Investing Activities | -33.28 | 55.85 | -14.55 | 24.43 | 45.12 | 31.46 | 29.93 | 3.43 | 25.60 | 11.24 | 14.84 | -62.13 | -171.49 | 9.99 | 8.48 | 6.70 | -0.53 | NA | |
Net Cash Provided By Used In Financing Activities | -0.18 | 48.56 | 0.02 | NA | NA | 0.00 | 0.03 | 0.01 | 0.29 | 0.35 | 1.26 | 0.03 | 214.83 | -1.08 | 82.69 | 34.43 | NA | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -16.16 | -19.42 | -16.73 | -18.62 | -26.46 | -23.84 | -28.06 | -16.32 | -18.72 | -12.99 | -14.34 | -11.07 | -14.04 | -11.35 | 2.19 | -10.45 | -7.62 | NA | |
Net Income Loss | -18.50 | -17.69 | -27.54 | -21.35 | -20.72 | -25.41 | -24.64 | -27.37 | 7.85 | -17.41 | -23.60 | -11.81 | -12.01 | -11.83 | -5.97 | -6.79 | -7.37 | -7.28 | |
Increase Decrease In Accounts Payable | 0.91 | -0.47 | 0.02 | -2.98 | -2.20 | 4.36 | -2.67 | 3.22 | 7.02 | 1.75 | -2.14 | 1.24 | -0.05 | 0.25 | -0.50 | -1.45 | 2.23 | NA | |
Share Based Compensation | 2.48 | 1.64 | 1.76 | 1.85 | 1.68 | 1.69 | 1.72 | 1.53 | 1.22 | 1.34 | 1.73 | 1.18 | 0.64 | 0.31 | 0.14 | 0.17 | 0.16 | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Investing Activities | -33.28 | 55.85 | -14.55 | 24.43 | 45.12 | 31.46 | 29.93 | 3.43 | 25.60 | 11.24 | 14.84 | -62.13 | -171.49 | 9.99 | 8.48 | 6.70 | -0.53 | NA | |
Payments To Acquire Property Plant And Equipment | NA | 0.02 | 0.02 | 0.30 | 0.07 | 0.69 | 0.75 | 7.68 | 1.99 | 0.96 | 2.33 | 2.64 | 0.20 | 0.10 | 0.32 | 0.11 | 0.03 | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Financing Activities | -0.18 | 48.56 | 0.02 | NA | NA | 0.00 | 0.03 | 0.01 | 0.29 | 0.35 | 1.26 | 0.03 | 214.83 | -1.08 | 82.69 | 34.43 | NA | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.11 | 0.71 | 0.69 | 0.20 | 0.06 | 0.39 | 0.21 | 0.05 | 30.08 | 1.90 | -4.23 | 2.27 | 1.34 | 2.44 | 3.18 | 2.98 | 2.82 | 1.78 | |
Ono Pharmaceutical Co., License | 0.80 | NA | NA | NA | 0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Immuno Gen, Collaborative Arrangement | 0.30 | NA | NA | NA | 0.10 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Revenue From Contract With Customer Excluding Assessed Tax | 1.11 | 0.71 | 0.69 | 0.20 | 0.06 | 0.39 | 0.21 | 0.05 | 30.08 | 1.90 | -4.23 | 2.27 | 1.34 | 2.44 | 3.18 | 2.98 | 2.82 | 1.78 | |
Ono Pharmaceutical Co., License | 0.80 | NA | NA | NA | 0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Immuno Gen, Collaborative Arrangement | 0.30 | NA | NA | NA | 0.10 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |